William M. Lee

1.8k total citations
17 papers, 1.1k citations indexed

About

William M. Lee is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, William M. Lee has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 13 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in William M. Lee's work include Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (9 papers) and Liver Disease Diagnosis and Treatment (6 papers). William M. Lee is often cited by papers focused on Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (9 papers) and Liver Disease Diagnosis and Treatment (6 papers). William M. Lee collaborates with scholars based in United States, Kenya and United Kingdom. William M. Lee's co-authors include Frank Vinholt Schiødt, Robert J. Fontana, Paul J. Pockros, Kris V. Kowdley, Risë Stribling, Robert Reindollar, Evren Atillasoy, Amer Shakil, Jean DePamphilis and Cary Caldwell and has published in prestigious journals such as Hepatology, Clinical Infectious Diseases and Ophthalmology.

In The Last Decade

William M. Lee

17 papers receiving 1.1k citations

Peers

William M. Lee

HEPAT

EPIDE

PHARM

SURGE

RHEUM

Roger Williams United Kingdom

SHOU‐DONG LEE Taiwan

David Bernstein United States

Manuel Mendizábal Argentina

Giovanni Perricone Italy

Marcelo Silva Argentina

Xavier Causse France

Zeki Karasu Türkiye

Preston P. Purdum United States

Hemda Schmilovitz‐Weiss Israel

Roger Williams United Kingdom

William M. Lee

557 ×0.7

HEPAT

427 ×0.6

EPIDE

105 ×0.4

PHARM

161 ×1.1

SURGE

43 ×0.4

RHEUM

Citations per year, relative to William M. Lee William M. Lee (= 1×) peers Roger Williams

Countries citing papers authored by William M. Lee

Since Specialization

Citations

This map shows the geographic impact of William M. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William M. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William M. Lee more than expected).

Fields of papers citing papers by William M. Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William M. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William M. Lee. The network helps show where William M. Lee may publish in the future.

Co-authorship network of co-authors of William M. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of William M. Lee. A scholar is included among the top collaborators of William M. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William M. Lee. William M. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Lok, Anna S., Lilia Ganova‐Raeva, Yona Keich Cloonan, et al.. (2017). Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment. Journal of Viral Hepatitis. 24(11). 1032–1042. 9 indexed citations

Jain, Mamta K., et al.. (2007). Do HIV Care Providers Appropriately Manage Hepatitis B in Coinfected Patients Treated with Antiretroviral Therapy?. Clinical Infectious Diseases. 44(7). 996–1000. 21 indexed citations

Jain, Mamta K., Lorraine Comanor, A. Clinton White, et al.. (2006). Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV‐coinfected patients: factors associated with response. Journal of Viral Hepatitis. 14(3). 176–182. 53 indexed citations

Lee, William M., Kevin Brown, Neal S. Young, et al.. (2006). Brief Report: No Evidence for Parvovirus B19 or Hepatitis E Virus as a Cause of Acute Liver Failure. Digestive Diseases and Sciences. 51(10). 1712–1715. 19 indexed citations

Wai, Chun Tao, Robert J. Fontana, Julie Polson, et al.. (2005). Clinical outcome and virological characteristics of hepatitis B‐related acute liver failure in the United States. Journal of Viral Hepatitis. 12(2). 192–198. 97 indexed citations

Schiødt, Frank Vinholt, et al.. (2003). Thrombopoietin in Acute Liver Failure. Hepatology. 37(3). 558–561. 53 indexed citations

Teo, Eng Kiong, George Ostapowicz, Munira Hussain, et al.. (2001). Hepatitis B Infection in Patients With Acute Liver Failure in the United States. Hepatology. 33(4). 972–976. 35 indexed citations

Reddy, K. Rajender, Teresa L. Wright, Paul J. Pockros, et al.. (2001). Efficacy and Safety of Pegylated (40–Kd) Interferon α–2A Compared With Interferon α–2A in Noncirrhotic Patients With Chronic Hepatitis C. Hepatology. 33(2). 433–438. 284 indexed citations

Fontana, Robert J., et al.. (1999). Acute liver failure associated with prolonged use of bromfenac leading to liver transplantation. Liver Transplantation and Surgery. 5(6). 480–484. 52 indexed citations

10.

Schiødt, Frank Vinholt, Evren Atillasoy, Amer Shakil, et al.. (1999). Etiology and outcome for 295 patients with acute liver failure in the united states. Liver Transplantation and Surgery. 5(1). 29–34. 288 indexed citations

11.

Pockros, Paul J., Myron J. Tong, William M. Lee, et al.. (1998). Relationship between biochemical and virological responses to interferon therapy in chronic hepatitis C infection. Journal of Viral Hepatitis. 5(4). 271–276. 14 indexed citations

12.

Hamid, Saeed, et al.. (1998). Urticarial vasculitis caused by hepatitis C virus infection: Response to interferon alfa therapy. Journal of the American Academy of Dermatology. 39(2). 278–280. 27 indexed citations

13.

Lee, William M.. (1998). The case for case reports.. PubMed. 30(3). 318–9. 1 indexed citations

14.

Thiele, Dwain L., et al.. (1996). Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients.. PubMed. 91(2). 300–8. 17 indexed citations

15.

Lee, William M., Robert M. Galbraith, George Watt, et al.. (1995). Predicting survival in fulminant hepatic failure using serum Gc protein concentrations.. PubMed. 21(1). 101–5. 73 indexed citations

16.

Wilson, Steven E., et al.. (1994). Mooren-type Hepatitis C Virus-associated Corneal Ulceration. Ophthalmology. 101(4). 736–745. 72 indexed citations

17.

Lee, William M., et al.. (1987). Antibodies to polymerized human serum albumin in acute and chronic liver disease. Hepatology. 7(5). 906–912. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact